Pharmaceuticals New Zealand

New Zealand Proteomics Market Analysis, 2024–2034

Updated Reviewed by Vidhi Upadhyay

New Zealand Proteomics Market Industry Trends and Forecast to 2034: Segmented by (Product, Application, End User, Region) - Growth, Market Size, Future Prospects & Competitive Analysis, 2024-2034

Overview

Market Dashboard

New Zealand · 2024–2034 · placeholder estimates

Values shown here are placeholder estimates, not researched figures. Researched 2024 historical, 2025 base-year and 2026–2034 forecast values are prepared with the full report.

Estimate 2024 $370.9 Mn Placeholder estimate
Estimate 2025 $415.1 Mn 1.1% of the global market
Projected 2034 $1.14 Bn 175.1% Adds $726.8 Mn over 9 forecast years
CAGR 2025–2034 11.9% Faster than 66% of 160 Pharmaceuticals markets here
Key players 5
  • New Zealand is 1.1% of the global market.
  • In APAC, the largest is China at $2.90 Bn.
  • Fastest growing: India at 15.2% a year.
  • New Zealand ranks 5th of 10 by size in APAC.

Market size projection

New Zealand

Source: Acuitas Health Analytics. Full methods, sources and usage terms come with report purchase.

Value added each year

$726.8 Mn total, 2026–2034

Year-by-year market size, 2024–2034
Proteomics Market market size by year, New Zealand
YearMarket sizeChange that yearSince 2025
2024 (estimate) $370.9 Mn — —
2025 (base) $415.1 Mn +$44.1 Mn —
2026 (forecast) $464.5 Mn +$49.4 Mn +11.9%
2027 (forecast) $519.8 Mn +$55.3 Mn +25.2%
2028 (forecast) $581.6 Mn +$61.9 Mn +40.1%
2029 (forecast) $650.8 Mn +$69.2 Mn +56.8%
2030 (forecast) $728.3 Mn +$77.4 Mn +75.4%
2031 (forecast) $814.9 Mn +$86.7 Mn +96.3%
2032 (forecast) $911.9 Mn +$97.0 Mn +119.7%
2033 (forecast) $1.02 Bn +$108.5 Mn +145.8%
2034 (forecast) $1.14 Bn +$121.4 Mn +175.1%

Placeholder estimates. Each year is projected from our earlier market estimate and its CAGR. Researched values come with the full report.

Same market worldwide

By geography

  1. Global $37.63 Bn
  2. North America $16.95 Bn
  3. US $15.59 Bn
  4. APAC $8.55 Bn
  5. Europe $6.36 Bn
  6. Canada $3.37 Bn
  7. China $2.90 Bn
  8. Japan $2.49 Bn
  9. Latin America $1.72 Bn
  10. Middle East $1.52 Bn
  11. Germany $1.19 Bn
  12. UK $972.2 Mn
  13. Italy $916.4 Mn
  14. Brazil $937.0 Mn
  15. France $883.9 Mn
  16. India $763.1 Mn
  17. Spain $664.0 Mn
  18. Mexico $647.0 Mn
  19. Ecuador $651.2 Mn
  20. Saudi Arabia $627.6 Mn
  21. Africa $567.8 Mn
  22. Australia $520.9 Mn
  23. Russia $419.2 Mn
  24. New Zealand (this report) $415.1 Mn
  25. South Africa $284.6 Mn
  26. UAE $185.1 Mn
  27. Egypt $115.1 Mn
  28. Philippines $81.6 Mn
  29. Malaysia $61.0 Mn
  30. Hong Kong $58.9 Mn
  31. Thailand $48.9 Mn
  32. Singapore $42.5 Mn
  33. Kenya $28.7 Mn

Report snapshot

New Zealand Proteomics Market Analysis at a glance
Market size, 2025$415.1 Mn placeholder estimate
Forecast, 2034$1.14 Bn placeholder estimate
Growth (CAGR), 2025–203411.9% placeholder estimate
Years2024 historical · 2025 base year · 2026–2034 forecast
SegmentsProduct, application and end user (see all)
Key playersThermo Fisher Scientific Inc., Olink (Thermo Fisher), SomaLogic (Standard BioTools), Bruker, Seer (see all)
Regulator in New ZealandMedsafeSource: Medsafe. Checked 14 Nov 2026.
FormatsPDF, PPTX, XLSX

Sizes and growth here are placeholder estimates, not researched figures. Researched figures come with the full report.

The New Zealand Proteomics Market Analysis Executive Summary

Proteomics measures thousands of proteins in blood and tissue to find disease markers and new drug targets.

Key segments of the proteomics market include product (Instruments, Reagents and Services) and application (Drug Discovery, Clinical Diagnostics and Biomarker Research).

Bar chart: New Zealand Proteomics market size, 2024–2034, placeholder estimates. $370.9 Mn in 2024, $415.1 Mn in 2025 and $1.14 Bn in 2034, 11.9% CAGR.
New Zealand Proteomics market size, 2024–2034. Placeholder estimates; researched figures come with the full report. Source: Acuitas Health Analytics.

New Zealand Proteomics Market Dynamics

Market Growth Drivers

The falling cost of DNA sequencing, more targeted medicines, large national genome programmes and growing use of genetic results in everyday care are driving the proteomics market.

Opportunity

Routine use of genomics in screening, pharmacy and primary care gives the proteomics market large room to grow.

Market Restraints

Data privacy concerns, limited reimbursement for some tests, shortages of genetic counsellors and complex data analysis hold back the proteomics market.

Competitive Landscape for Proteomics Market in New Zealand

The proteomics market is moderately concentrated. Leading companies compete on product innovation, clinical evidence, pricing and geographic reach, and use partnerships and acquisitions to expand their portfolios.

Key Players

Healthcare Policies and Regulatory Landscape for Proteomics Market in New Zealand

Proteomics in New Zealand: rules and payment

Medsafe, part of the Ministry of Health, approves medicines before they can be sold.⁠[1] Pharmac decides which medicines and medical devices the public health system pays for.⁠[2]

[1] Medsafe. Checked 14 Nov 2026.

[2] Pharmac. Checked 14 Nov 2026.

Policy changes and Reimbursement scenario

Regulators such as the US FDA, the European Medicines Agency and national drug authorities set approval, pricing and safety rules for proteomics. Reimbursement decisions by public payers and insurers shape how fast new therapies reach patients in New Zealand.

Beyond the market numbers

Research, trials and patients

What doctors and scientists are doing in Proteomics right now, from free public sources.

Latest research 45,139 papers since 2021 (worldwide)

  1. Capturing and Characterizing Wild Yeast for Beer Brewing. Journal of proteome research, 2026
  2. CONCLAVE: A consensus clustering with annotation-validation extrapolation for cyclic multiplexed immunofluorescence data. Cell reports methods, 2026
  3. Population-scale integration of spatial omics networks for clinical prediction and biological discovery by SPIN. Cell genomics, 2026
  4. Unveiling novel therapeutic targets and potent hits to combat antimicrobial resistance in Bacteroides fragilis. Computational biology and chemistry, 2026
  5. Recombinant equine lubricin is safe and well tolerated following multiple intra-articular injections in healthy fetlock joints. American journal of veterinary research, 2026
Search all of them on PubMed (opens in a new tab)

Sources: PubMed (US National Library of Medicine), ClinicalTrials.gov, World Bank. Fetched 12 Nov 2026. Papers and trials are found by search words, so the counts are a guide. Titles only; read each paper at its source.

Public data, with sources

Proteomics in context

New Zealand compared

  • Health spending per person: 5,022 US$ per person (2024). World: 1,317 US$ per person (2023). 2nd highest of the 15 countries we cover in APAC.[1]
  • Doctors: 3.61 per 1,000 people (2022). World: 1.86 per 1,000 people (2022). 2nd highest of the 15 countries we cover in APAC.[2]
  • People aged 65 and over: 17.6% of people (2025). World: 10.4% of people (2025). 4th highest of the 16 countries we cover in APAC.[3]

[1] World Bank Open Data, Health spending per person (US$ per person). Retrieved 14 Nov 2026.

[2] World Bank Open Data, Doctors (per 1,000 people). Retrieved 14 Nov 2026.

[3] World Bank Open Data, People aged 65 and over (% of people). Retrieved 15 Nov 2026.

Free data on this topic

Quick answers

Frequently asked questions

How big is the Proteomics market in New Zealand?
Placeholder estimate: about $415.1 Mn in 2025, rising to about $1.14 Bn by 2034. These are early estimates, not researched figures; the researched values come with the full report.
How fast is the Proteomics market in New Zealand growing?
Placeholder estimate: about 11.9% a year (CAGR, 2025–2034). The researched growth rate comes with the full report.
What segments does the Proteomics market report cover?
The report splits the market by product (Instruments, Reagents, Services, Software), application (Drug Discovery, Clinical Diagnostics, Biomarker Research) and end user (Hospitals, Specialty Clinics, Retail Pharmacies, Online Pharmacies).
Who are the key players in the Proteomics market?
Key players include Thermo Fisher Scientific Inc., Olink (Thermo Fisher), SomaLogic (Standard BioTools), Bruker and Seer.
What is driving the Proteomics market?
The falling cost of DNA sequencing, more targeted medicines, large national genome programmes and growing use of genetic results in everyday care are driving the proteomics market.
Who regulates Proteomics in New Zealand?
Medsafe, part of the Ministry of Health, approves medicines before they can be sold. Source: Medsafe. Checked 14 Nov 2026.
How is healthcare paid for in New Zealand?
Pharmac decides which medicines and medical devices the public health system pays for. Source: Pharmac. Checked 14 Nov 2026.
How much research is published on Proteomics?
PubMed lists 45,139 papers on Proteomics added since January 2021, worldwide. Source: PubMed, Papers added since 1 January 2021 matching this market. Retrieved 12 Nov 2026.
Get a free sample The table of contents and sample pages. No payment needed. Request sample Consult Us Questions about Proteomics in New Zealand? Our analysts can size it for your plan. Talk to us See the public data Health figures for every country, free. Open the Public Health Dashboard
Back to Catalogue
Keep exploring

Related Pharmaceuticals reports in New Zealand

See all
Same topic, other categories

Related on genomics

See the topic